Dr. Klaus Kleinfeld is an international manager, investor, and entrepreneur. He is founder and CEO of K2Elevation, a company that invests in and develops international enterprises in the technology and biotech segment.

He is Chairman of KONUX and Chairman of FERNRIDE, a member of the supervisory boards of GreyOrange, Fero Labs and NEOM as well as an Advisory Partner at EMH Partners. From 2008 to 2017, he was Chairman and CEO of Alcoa/Arconic. Previously, Dr. Kleinfeld had a 20-year career with Siemens, where he ended up serving as CEO of Siemens AG until 2007. He’s served as an advisor to several US Presidents as well as European, Asian, and Middle Eastern government leaders.

Dr. Kleinfeld is an Honorary Senator of the Lindau Nobel Laureates Meeting, an Honorary Trustee of the Brookings Institution, a lifetime member of the Council on Foreign Relations and a member of the Board of Directors of The Metropolitan Opera.

He was born in Bremen, Germany and holds an MBA from the University of Goettingen and a PhD from the University of Wuerzburg. A dual US and German citizen, Dr. Kleinfeld lives with his family in New York.